Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.24 USD | -0.07% | -0.34% | +507.51% |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Apr. 01 | HC Wainwright Downgrades Landos Biopharma to Neutral From Buy | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.5M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -46M | EV / Sales 2024 * | - |
Net cash position 2024 * | 72.5M | Net cash position 2025 * | 30M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.46
x | P/E ratio 2025 * |
-13.2
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.54% |
1 day | -0.07% | ||
1 week | -0.34% | ||
Current month | -0.29% | ||
1 month | +3.42% | ||
3 months | +321.12% | ||
6 months | +442.32% | ||
Current year | +507.51% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Oakes
CEO | Chief Executive Officer | 56 | 22-06-20 |
Claudia Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Dawn Louro
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 17-08-31 | |
Tim Mayleben
BRD | Director/Board Member | 63 | 21-05-12 |
Alka Batycky
BRD | Director/Board Member | 54 | 23-05-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 22.24 | -0.07% | 3,863 |
24-05-02 | 22.25 | -0.19% | 6,316 |
24-05-01 | 22.29 | -0.03% | 9,671 |
24-04-30 | 22.3 | -0.80% | 1,677 |
24-04-29 | 22.48 | +0.76% | 3,969 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+507.51% | 69.5M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- LABP Stock